Evidence map›Paper›PMID 39519246›Full record

Observational studyInternational journal of molecular sciences2024

A Prospective Observational Study on Analyzing Lung Cancer Gene Mutation Variant Allele Frequency (VAF) and Its Correlation with Treatment Efficacy.

Yusuke Shinozaki, Kei Morikawa, Hirotaka Kida, Hiroshi Handa, Hisashi Saji, Seiji Nakamura, Yoshiharu Sato, Yumi Ueda, Fumihiko Suzuki, Ryo Matoba and 1 more

Abstract readObservational Study
In one paragraph

Observational study in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yusuke ShinozakiDivision of Respiratory Diseases, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki 216-8511, Japan.
Kei MorikawaDivision of Respiratory Diseases, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki 216-8511, Japan.ORCID 0000-0002-0745-5118
Hirotaka KidaDivision of Respiratory Diseases, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki 216-8511, Japan.
Hiroshi HandaDivision of Respiratory Diseases, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki 216-8511, Japan.ORCID 0000-0003-4885-7612
Hisashi SajiDepartment of Chest Surgery, St. Marianna University School of Medicine, Kawasaki 216-8511, Japan.
Seiji NakamuraDNA Chip Research Inc., Kawasaki 211-0004, Japan.
Yoshiharu SatoDNA Chip Research Inc., Kawasaki 211-0004, Japan.
Yumi UedaDNA Chip Research Inc., Kawasaki 211-0004, Japan.
Fumihiko SuzukiDNA Chip Research Inc., Kawasaki 211-0004, Japan.
Ryo MatobaDNA Chip Research Inc., Kawasaki 211-0004, Japan.
Masamichi MineshitaDivision of Respiratory Diseases, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki 216-8511, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A few studies have reported on the variability of the variant allele frequency (VAF) of gene mutations and the relationship between VAF and the therapeutic effect of molecular-targeted drugs. This joint study was conducted from May 2020 to January 2022 between St. Marianna University School of Medicine and the DNA Chip Research Institute. Cytology samples were used to verify the usefulness of a lung cancer compact panel test, which is a high-sensitivity next-generation sequencing (NGS) gene panel test. We analyzed the distribution of VAF and the duration of the initial molecular-targeted drug administration in patients with advanced-stage epidermal growth factor receptor (

Indexed as

Carcinoma, Non-Small-Cell LungGene FrequencyLung NeoplasmsMutationAdultAgedAged, 80 and overErbB ReceptorsFemaleHigh-Throughput Nucleotide SequencingHumansMaleMiddle AgedMolecular Targeted TherapyProspective StudiesTreatment OutcomeEGFR protein, humanErbB Receptorscytology specimengene panel analysisnext-generation sequencingnon-small cell carcinoma (NSCLC)variant allele frequency (VAF)

Identifiers

PMID39519246
PMCPMC11546704

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.